Slit-robo signaling for diagnosis and treatment of kidney disease

• 收藏
• 分享

专利权人:

BOSTON MEDICAL CENTER CORPORATION

发明人:

Lu, Weining,Fan, Xueping,Salant, David

申请号：

NZ72443013

公开号：

NZ724430A

申请日:

2013.01.04

申请国别(地区):

NZ

年份:

2020

代理人:

摘要：

Disclosed is a pharmaceutical composition comprising a ROBO2 inhibitor, wherein the ROBO2 inhibitor is a soluble ROBO2 protein comprising a fusion polypeptide comprising both the Ig1 and Ig2 SLIT binding domains of ROBO2, with no intracellular ROBO2 domain. Also disclosed is the use of said composition in the treatment of chronic kidney disease or proteinuria.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/